UBS Group’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

UBS Group’s Portfolio ALXA Stock Details ALXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-14,529	Closed	-$7K	–	8272
2016 Q1	$7K	Buy	+14,529	New	+$6.36K	﹤0.01%	6893
2015 Q2	–	Sell	-3,489	Closed	-$7K	–	9161
2015 Q1	$7K	Sell	3,489 -6	-0.2%	-$12	﹤0.01%	7962
2014 Q4	$5K	Buy	+3,495	New	+$6.24K	﹤0.01%	9057

UBS Group's ALXA Position: Q2 2016 in Review

UBS Group sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 14,529 shares — an estimated $7K sold.

UBS Group first reported a position in ALXA in Q4 2014 and held it in 3 quarters. The position peaked at $7K in Q1 2016. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

UBS Group reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
UBS Group sold 14,529 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $7K.
UBS Group first reported a position in Alexza Pharmaceuticals Inc in Q4 2014 and held it in 3 quarters.
UBS Group's Alexza Pharmaceuticals Inc position peaked at $7K in Q1 2016.
0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on UBS Group's 13F filing for Q2 2016, filed 12 Aug 2016.